跳至主要内容
临床试验/NCT02008045
NCT02008045已完成不适用

Advanced MR Imaging of Perinatal Brain Injury: Correlation With Neurocognitive Outcome

University of Pittsburgh1 个研究点 分布在 1 个国家目标入组 557 人开始时间: 2009年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
557
试验地点
1
主要终点
Developmental Assessment

研究概览

简要总结

The purpose of this study is to collect and compare information from cranial ultrasounds, magnetic resonance imaging scans, neurological exam and neuropsychological assessments of children. The investigators hope that the information collected in this study will help with early screening, diagnosis and treatment of brain injury in newborns as well as identify a connection between MR imaging (MRI-magnetic resonance imaging, MRS-magnetic resonance spectroscopy) and neurodevelopmental outcome.

详细描述

In the last two decades, major advances have been made in the clinical care of premature and term infants, including in the management of sepsis and respiratory compromise that can contribute to neurological disabilities in survivors. The incidence of classic cystic periventricular leukomalacia (PVL) has declined and a more diffuse and non-cystic pattern of cerebral white matter injury is more predominant. Although multiple pathologies occur in premature infants, the principal variety accounting for the predominance of neurodevelopmental disability is PVL. This disability in very low birth weight infants (VLBW) (< 1500 grams) includes cognitive/behavioral deficits in 25-50% and cerebral palsy in 5-10%. Neuroimaging studies of VLBW survivors suggest that the cerebral palsy is related to the focal necrotic lesions of PVL, whereas the cognitive/behavioral deficits correlate with more diffuse cerebral white matter injury. PVL is defined as damaged immature cerebral white matter with periventricular focal necrosis ("focal" component) in association with diffuse reactive gliosis and microglial activation in the surrounding white matter ("diffuse" component). Of note, PVL occurs in the late preterm infant and the term infant, particularly in cases of congenital heart disease. The pathogenesis of perinatal white matter injury is currently thought to be related to a complex interaction between maternal/fetal infection, cytokines and hypoxia-ischemia which results in both the generation of reactive oxygen specific agents (oxidative stress), apoptotic oligodendrocyte cell death, and axonal injury. In long-term survivors with PVL, neuroimaging studies often demonstrate reduced cerebral white matter volume, impaired myelination, ventriculomegaly and reduced volume in the cerebral cortex, thalamus/basal ganglia and cerebellum. In many of these long-term studies, the preterm children studies had normal cranial ultrasound. Cranial ultrasound, however, is not adequate for assessing non-cystic focal or diffuse white matter injury. To date, there are no longitudinal MR studies of preterm or congenital heart disease infants which correlate advanced neonatal MR imaging techniques with long-term neurodevelopmental outcome or advanced MR techniques performed in the childhood period.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Day 至 7 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Preterm babies and neonates with congenital heart disease
  • Term Neonates

排除标准

  • Severe congenital brain malformation
  • Significant chromosomal abnormality / syndrome which could confound the neurodevelopmental follow up data
  • Preterm birth and congenital heart disease
  • Focal neurological abnormality
  • Chronic seizures
  • Severe congenital brain malformation
  • Significant chromosomal abnormality/ syndrome which could confound the neurodevelopmental follow up data
  • Major pregnancy complication (diabetes, eclampsia)
  • Significant birth trauma and/or hypoxic ischemic injury

研究组 & 干预措施

Neonates at Risk for Brian Injury

Magnetic Resonance Imaging Neurodevelopmental Testing - 18 Month

干预措施: Magnetic Resonance Imaging (Device)

Neonates at Risk for Brian Injury

Magnetic Resonance Imaging Neurodevelopmental Testing - 18 Month

干预措施: Neurodevelopmental Testing (Behavioral)

Term Neonates

Magnetic Resonance Imaging Neurodevelopmental Testing - 18 Month

干预措施: Magnetic Resonance Imaging (Device)

Term Neonates

Magnetic Resonance Imaging Neurodevelopmental Testing - 18 Month

干预措施: Neurodevelopmental Testing (Behavioral)

结局指标

主要结局

Developmental Assessment

时间窗: 18 Months

Administration of neurodevelopmental testing and completion of parent questionnaires regarding the child's development.

次要结局

  • Assessment of White Matter Injury in Brain(Baseline)
  • Changes in White Matter Injury from Baseline(at 6 Years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rafael Ceschin

Assistant Professor

University of Pittsburgh

研究点 (1)

Loading locations...

相似试验